戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 eprotonating the parent nitrile with lithium diethylamide.
2 th the prototypic hallucinogen lysergic acid diethylamide.
3  5-HT2A receptors by using [3H]lysergic acid diethylamide.
4  nM), mesulergine (100 nM) and lysergic acid diethylamide (1 microM) significantly reduced or abolish
5 propanoyl and (Ru(II)b'(2)m)(2+) is bis(4,4'-diethylamide-2,2'-bipyridine)(4-methyl,4'-carboxylate,2,
6 ceptor autoradiography with 3H-lysergic acid diethylamide (3H-LSD), 3H-8-hydroxy-2-[di-N-propylamine]
7 ies were determined using [3H]-lysergic acid diethylamide ([3H]-LSD) binding to cell membranes of hum
8 nabinol, and psychedelics like lysergic acid diethylamide all directly bind to GPCRs to initiate sign
9 the sample, most commonly LSD (lysergic acid diethylamide), amphetamines, Ecstasy (methylenedioxymeth
10 ffinity binding sites for 125I-lysergic acid diethylamide and [3H]mesulergine.
11   Psychedelic drugs, including lysergic acid diethylamide and other agonists of the serotonin 2A rece
12 erivatives of the best active compounds, the diethylamide and the dipropylamide, were also prepared.
13 ctive forms of the 1-(ethyl)propylamide, the diethylamide, and the dipropylamide (all of the same con
14  Classic hallucinogens such as lysergic acid diethylamide are thought to elicit their psychotropic ac
15                      The 1-ethylpropylamide, diethylamide, dipropylamide, and 4-morpholinylamide show
16       Additionally, illness or lysergic acid diethylamide exposure during pregnancy provokes coordina
17 pathway, whereas others (e.g., lysergic acid diethylamide) favored the PLA2-AA pathway.
18 group on the bisoxazole system using lithium diethylamide, followed by alkylation with an allylic bro
19 in vivo study, the C-1' active isomer of the diethylamide from the 1-carboxy series was tested in inf
20 11g (R1 = meta-CF(3), Ar2 = 4'biphenyl, R3 = diethylamide) illustrated the potency of this series wit
21  showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ERG), and relate
22 thamphetamine (known as MDMA), lysergic acid diethylamide (known as LSD), psilocybin, or ayahuasca) r
23 olunteers were randomized into lysergic acid diethylamide (LSD) (n = 40) and placebo (n = 40) groups
24                                Lysergic acid diethylamide (LSD) and 3,4-Methylenedioxymethamphetamine
25 epresent essential targets for lysergic acid diethylamide (LSD) and all other psychedelic drugs.
26 search on psychedelics such as lysergic acid diethylamide (LSD) and dissociative drugs such as phency
27 edelic compounds - psilocybin, lysergic acid diethylamide (LSD) and ketamine.
28 asked about: use of ayahuasca, lysergic acid diethylamide (LSD) and magic mushrooms; demographics, cu
29 ychedelics such as psilocybin, lysergic acid diethylamide (LSD) and N,N-dimethyltryptamine (DMT) to t
30   Psychedelic drugs, including lysergic acid diethylamide (LSD) and other agonists of the serotonin 2
31 Psychedelic substances such as lysergic acid diethylamide (LSD) and psilocybin show potential for the
32         Psychedelics including lysergic acid diethylamide (LSD) and psilocybin temporarily alter subj
33 al and experiential effects of lysergic acid diethylamide (LSD) are attributable to agonism of the se
34 '-dimethyltryptamine (DMT) and lysergic acid diethylamide (LSD) are undergoing a renaissance as poten
35 quantitation of (3)H-labeled d-lysergic acid diethylamide (LSD) binding to recombinant human 5-hydrox
36  reported that the psychedelic lysergic acid diethylamide (LSD) enhances empathy and social behavior
37                 Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very posit
38 c drugs such as psilocybin and lysergic acid diethylamide (LSD) have recaptured the imagination of bo
39 e is renewed interest in using lysergic acid diethylamide (LSD) in clinical psychiatric research and
40                                Lysergic acid diethylamide (LSD) is a non-selective serotonin-receptor
41                                Lysergic acid diethylamide (LSD) is a prototypical hallucinogen and it
42                                Lysergic acid diethylamide (LSD) is the prototypical psychedelic drug,
43 ed to elucidate the effects of lysergic acid diethylamide (LSD) on the human brain but the underlying
44 xy-4-iodoamphetamine (DOI) and lysergic acid diethylamide (LSD) stimulated a head-twitch behavioral r
45 igate the neural mechanisms of lysergic acid diethylamide (LSD) using regression dynamic causal model
46 -JRT, a structural analogue of lysergic acid diethylamide (LSD) with lower hallucinogenic potential a
47  investigating the efficacy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (M
48                                Lysergic acid diethylamide (LSD), a semisynthetic ergoline alkaloid an
49             Using the ergoline lysergic acid diethylamide (LSD), and a series of substituted tryptami
50  after acute administration of lysergic acid diethylamide (LSD), and after pretreatment with Ketanser
51 ychedelics such as psilocybin, lysergic acid diethylamide (LSD), and N,N-dimethyltryptamine (DMT) are
52 ltered states, including after lysergic acid diethylamide (LSD), complexity is increased.
53 dosing psychedelics, including lysergic acid diethylamide (LSD), has gained attention for its potenti
54 r 5-HT2A receptor ligands like lysergic acid diethylamide (LSD), in which the amine nitrogen is embed
55 eated use of very low doses of lysergic acid diethylamide (LSD), known as microdosing, improves mood
56 ing mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perception, cognit
57 The classical psychedelics (+)-lysergic acid diethylamide (LSD), psilocybin, and mescaline exert thei
58             Hallucinogens like lysergic acid diethylamide (LSD), psilocybin, and substituted N-benzyl
59 opofol, sevoflurane, ketamine, lysergic acid diethylamide (LSD), psilocybin, N,N-Dimethyltryptamine (
60 s underlie the peak effects of lysergic acid diethylamide (LSD), we applied dynamic causal modeling t
61 delics, such as psilocybin and lysergic acid diethylamide (LSD), which have a key locus of action at
62 ate the efficacy and safety of lysergic acid diethylamide (LSD)-assisted therapy in patients who expe
63 re positive view of the use of lysergic acid diethylamide (LSD).
64 taarr2 preferring, relative to lysergic acid diethylamide (LSD).
65 acebo) and during ingestion of lysergic acid diethylamide (LSD).
66               The hallucinogen lysergic acid diethylamide (LSD; 0.1 mg/kg, i.p.) caused a time-depend
67 s, reporting on "psilocybin," "lysergic acid diethylamide," "LSD," "ayahuasca," "3,4-methylenedioxyme
68  the conformational selectivity of LSD's key diethylamide moiety.
69 ther drug use (eg, cocaine and lysergic acid diethylamide; odds ratio [OR], 1.73; 95% CI, 1.66-1.80)
70                                    Using the diethylamide of 3,5-dinitrobenzoic acid as a model compo
71                              Replacing the p-diethylamide of the known potent delta opioid receptor s
72   The hallucinogens studied [d-lysergic acid diethylamide, psilocin, bufotenin, and (+/-)-1-(2,5-dime
73  chiral center), and the diastereomer of the diethylamide representing the active form at both C-1' a
74  drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR and resemble some of the c
75 receptor selective agonist BW373U86 with a m-diethylamide resulted in a compound with agonist activit
76       Reactions with the N-based nucleophile diethylamide results in the formation of free diethylnit
77 for the 5-HT2C receptor) and d-lysergic acid diethylamide (selective for the 5-HT2A receptor), revers
78 higher risk of dependence than lysergic acid diethylamide users.
79        Phenylphosphonic acid ethyl ester N,N-diethylamide was subjected to a double modification of i